1XU.F Entheon Biomedical Corp.

Healthcare Biotechnology Frankfurt Exchange
0.0300 EUR
Close of Nov 11, 2026
0.0050 0.0670
Market cap
EUR 416K
P/E
3.0x
P/B
1.36x
ROE
64.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to May 2026.

Is 1XU.F undervalued?

Graham number
Price0.0300
Graham value0.0703
Discount57.3%

1XU.F trades 57.3% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Entheon Biomedical Corp. fundamental analysis

No fundamental analysis for Entheon Biomedical Corp. yet.

Entheon Biomedical Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Entheon Biomedical Corp.

Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

Full company profile